Global and United States Prostate Cancer Therapeutics Drugs Market Insights, Forecast to 2026

Global and United States Prostate Cancer Therapeutics Drugs Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Prostate Cancer Therapeutics Drugs Product Introduction
1.2 Market Segments
1.3 Key Prostate Cancer Therapeutics Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Prostate Cancer Therapeutics Drugs Market Size Growth Rate by Type
1.4.2 Hormone Therapy
1.4.3 Chemotherapy
1.4.4 Biologic Therapy
1.4.5 Targeted Therapy
1.4.6 Other
1.5 Market by Application
1.5.1 Global Prostate Cancer Therapeutics Drugs Market Size Growth Rate by Application
1.5.2 Hospital Pharmacy
1.5.3 Retail Pharmacy
1.5.4 Online Sales
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Prostate Cancer Therapeutics Drugs Market Size, Estimates and Forecasts
2.1.1 Global Prostate Cancer Therapeutics Drugs Revenue 2015-2026
2.1.2 Global Prostate Cancer Therapeutics Drugs Sales 2015-2026
2.2 Global Prostate Cancer Therapeutics Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Prostate Cancer Therapeutics Drugs Historical Market Size by Region (2015-2020)
2.3.1 Global Prostate Cancer Therapeutics Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Prostate Cancer Therapeutics Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Prostate Cancer Therapeutics Drugs Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Prostate Cancer Therapeutics Drugs Sales Forecast by Region (2021-2026)
2.4.2 Global Prostate Cancer Therapeutics Drugs Revenue Forecast by Region (2021-2026)
3 Global Prostate Cancer Therapeutics Drugs Competitor Landscape by Players
3.1 Global Top Prostate Cancer Therapeutics Drugs Sales by Manufacturers
3.1.1 Global Prostate Cancer Therapeutics Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Prostate Cancer Therapeutics Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Global Prostate Cancer Therapeutics Drugs Manufacturers by Revenue
3.2.1 Global Prostate Cancer Therapeutics Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Prostate Cancer Therapeutics Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Prostate Cancer Therapeutics Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Prostate Cancer Therapeutics Drugs Revenue in 2019
3.2.5 Global Prostate Cancer Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Prostate Cancer Therapeutics Drugs Price by Manufacturers
3.4 Global Prostate Cancer Therapeutics Drugs Manufacturing Base Distribution, Product Types
3.4.1 Prostate Cancer Therapeutics Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Prostate Cancer Therapeutics Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Prostate Cancer Therapeutics Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Prostate Cancer Therapeutics Drugs Market Size by Type (2015-2020)
4.1.1 Global Prostate Cancer Therapeutics Drugs Sales by Type (2015-2020)
4.1.2 Global Prostate Cancer Therapeutics Drugs Revenue by Type (2015-2020)
4.1.3 Prostate Cancer Therapeutics Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Prostate Cancer Therapeutics Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Prostate Cancer Therapeutics Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Prostate Cancer Therapeutics Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Prostate Cancer Therapeutics Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Prostate Cancer Therapeutics Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Prostate Cancer Therapeutics Drugs Market Size by Application (2015-2020)
5.1.1 Global Prostate Cancer Therapeutics Drugs Sales by Application (2015-2020)
5.1.2 Global Prostate Cancer Therapeutics Drugs Revenue by Application (2015-2020)
5.1.3 Prostate Cancer Therapeutics Drugs Price by Application (2015-2020)
5.2 Prostate Cancer Therapeutics Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Prostate Cancer Therapeutics Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Prostate Cancer Therapeutics Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Prostate Cancer Therapeutics Drugs Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Prostate Cancer Therapeutics Drugs Market Size YoY Growth 2015-2026
6.1.1 United States Prostate Cancer Therapeutics Drugs Sales YoY Growth 2015-2026
6.1.2 United States Prostate Cancer Therapeutics Drugs Revenue YoY Growth 2015-2026
6.1.3 United States Prostate Cancer Therapeutics Drugs Market Share in Global Market 2015-2026
6.2 United States Prostate Cancer Therapeutics Drugs Market Size by Players (International and Local Players)
6.2.1 United States Top Prostate Cancer Therapeutics Drugs Players by Sales (2015-2020)
6.2.2 United States Top Prostate Cancer Therapeutics Drugs Players by Revenue (2015-2020)
6.3 United States Prostate Cancer Therapeutics Drugs Historic Market Review by Type (2015-2020)
6.3.1 United States Prostate Cancer Therapeutics Drugs Sales Market Share by Type (2015-2020)
6.3.2 United States Prostate Cancer Therapeutics Drugs Revenue Market Share by Type (2015-2020)
6.3.3 United States Prostate Cancer Therapeutics Drugs Price by Type (2015-2020)
6.4 United States Prostate Cancer Therapeutics Drugs Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Prostate Cancer Therapeutics Drugs Sales Forecast by Type (2021-2026)
6.4.2 United States Prostate Cancer Therapeutics Drugs Revenue Forecast by Type (2021-2026)
6.4.3 United States Prostate Cancer Therapeutics Drugs Price Forecast by Type (2021-2026)
6.5 United States Prostate Cancer Therapeutics Drugs Historic Market Review by Application (2015-2020)
6.5.1 United States Prostate Cancer Therapeutics Drugs Sales Market Share by Application (2015-2020)
6.5.2 United States Prostate Cancer Therapeutics Drugs Revenue Market Share by Application (2015-2020)
6.5.3 United States Prostate Cancer Therapeutics Drugs Price by Application (2015-2020)
6.6 United States Prostate Cancer Therapeutics Drugs Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Prostate Cancer Therapeutics Drugs Sales Forecast by Application (2021-2026)
6.6.2 United States Prostate Cancer Therapeutics Drugs Revenue Forecast by Application (2021-2026)
6.6.3 United States Prostate Cancer Therapeutics Drugs Price Forecast by Application (2021-2026)
7 North America
7.1 North America Prostate Cancer Therapeutics Drugs Market Size YoY Growth 2015-2026
7.2 North America Prostate Cancer Therapeutics Drugs Market Facts & Figures by Country
7.2.1 North America Prostate Cancer Therapeutics Drugs Sales by Country (2015-2020)
7.2.2 North America Prostate Cancer Therapeutics Drugs Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Prostate Cancer Therapeutics Drugs Market Size YoY Growth 2015-2026
8.2 Europe Prostate Cancer Therapeutics Drugs Market Facts & Figures by Country
8.2.1 Europe Prostate Cancer Therapeutics Drugs Sales by Country
8.2.2 Europe Prostate Cancer Therapeutics Drugs Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Prostate Cancer Therapeutics Drugs Market Size YoY Growth 2015-2026
9.2 Asia Pacific Prostate Cancer Therapeutics Drugs Market Facts & Figures by Country
9.2.1 Asia Pacific Prostate Cancer Therapeutics Drugs Sales by Region (2015-2020)
9.2.2 Asia Pacific Prostate Cancer Therapeutics Drugs Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Prostate Cancer Therapeutics Drugs Market Size YoY Growth 2015-2026
10.2 Latin America Prostate Cancer Therapeutics Drugs Market Facts & Figures by Country
10.2.1 Latin America Prostate Cancer Therapeutics Drugs Sales by Country
10.2.2 Latin America Prostate Cancer Therapeutics Drugs Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Prostate Cancer Therapeutics Drugs Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Prostate Cancer Therapeutics Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Prostate Cancer Therapeutics Drugs Sales by Country
11.2.2 Middle East and Africa Prostate Cancer Therapeutics Drugs Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Johnson & Johnson
12.1.1 Johnson & Johnson Corporation Information
12.1.2 Johnson & Johnson Description and Business Overview
12.1.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Johnson & Johnson Prostate Cancer Therapeutics Drugs Products Offered
12.1.5 Johnson & Johnson Recent Development
12.2 Pfizer, Inc
12.2.1 Pfizer, Inc Corporation Information
12.2.2 Pfizer, Inc Description and Business Overview
12.2.3 Pfizer, Inc Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Pfizer, Inc Prostate Cancer Therapeutics Drugs Products Offered
12.2.5 Pfizer, Inc Recent Development
12.3 AstraZeneca
12.3.1 AstraZeneca Corporation Information
12.3.2 AstraZeneca Description and Business Overview
12.3.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
12.3.4 AstraZeneca Prostate Cancer Therapeutics Drugs Products Offered
12.3.5 AstraZeneca Recent Development
12.4 Amgen, Inc
12.4.1 Amgen, Inc Corporation Information
12.4.2 Amgen, Inc Description and Business Overview
12.4.3 Amgen, Inc Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Amgen, Inc Prostate Cancer Therapeutics Drugs Products Offered
12.4.5 Amgen, Inc Recent Development
12.5 AbbVie, Inc
12.5.1 AbbVie, Inc Corporation Information
12.5.2 AbbVie, Inc Description and Business Overview
12.5.3 AbbVie, Inc Sales, Revenue and Gross Margin (2015-2020)
12.5.4 AbbVie, Inc Prostate Cancer Therapeutics Drugs Products Offered
12.5.5 AbbVie, Inc Recent Development
12.6 Bayer AG
12.6.1 Bayer AG Corporation Information
12.6.2 Bayer AG Description and Business Overview
12.6.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Bayer AG Prostate Cancer Therapeutics Drugs Products Offered
12.6.5 Bayer AG Recent Development
12.7 Ipsen Group
12.7.1 Ipsen Group Corporation Information
12.7.2 Ipsen Group Description and Business Overview
12.7.3 Ipsen Group Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Ipsen Group Prostate Cancer Therapeutics Drugs Products Offered
12.7.5 Ipsen Group Recent Development
12.8 Sanofi
12.8.1 Sanofi Corporation Information
12.8.2 Sanofi Description and Business Overview
12.8.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Sanofi Prostate Cancer Therapeutics Drugs Products Offered
12.8.5 Sanofi Recent Development
12.9 Endo Pharmaceuticals
12.9.1 Endo Pharmaceuticals Corporation Information
12.9.2 Endo Pharmaceuticals Description and Business Overview
12.9.3 Endo Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Endo Pharmaceuticals Prostate Cancer Therapeutics Drugs Products Offered
12.9.5 Endo Pharmaceuticals Recent Development
12.10 Dendreon Corporation
12.10.1 Dendreon Corporation Corporation Information
12.10.2 Dendreon Corporation Description and Business Overview
12.10.3 Dendreon Corporation Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Dendreon Corporation Prostate Cancer Therapeutics Drugs Products Offered
12.10.5 Dendreon Corporation Recent Development
12.11 Johnson & Johnson
12.11.1 Johnson & Johnson Corporation Information
12.11.2 Johnson & Johnson Description and Business Overview
12.11.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Johnson & Johnson Prostate Cancer Therapeutics Drugs Products Offered
12.11.5 Johnson & Johnson Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Prostate Cancer Therapeutics Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Prostate Cancer Therapeutics Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Prostate Cancer Therapeutics Drugs Market Segments
Table 2. Ranking of Global Top Prostate Cancer Therapeutics Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Prostate Cancer Therapeutics Drugs Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Hormone Therapy
Table 5. Major Manufacturers of Chemotherapy
Table 6. Major Manufacturers of Biologic Therapy
Table 7. Major Manufacturers of Targeted Therapy
Table 8. Major Manufacturers of Other
Table 9. Global Prostate Cancer Therapeutics Drugs Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Prostate Cancer Therapeutics Drugs Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Prostate Cancer Therapeutics Drugs Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Prostate Cancer Therapeutics Drugs Sales Market Share by Regions (2015-2020)
Table 13. Global Prostate Cancer Therapeutics Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Prostate Cancer Therapeutics Drugs Sales Forecast by Region (2021-2026) (K Pcs)
Table 15. Global Prostate Cancer Therapeutics Drugs Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Prostate Cancer Therapeutics Drugs Sales Share by Manufacturers (2015-2020)
Table 17. Global Prostate Cancer Therapeutics Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Prostate Cancer Therapeutics Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Therapeutics Drugs as of 2019)
Table 19. Prostate Cancer Therapeutics Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Prostate Cancer Therapeutics Drugs Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Prostate Cancer Therapeutics Drugs Price (2015-2020) (USD/Pcs)
Table 22. Prostate Cancer Therapeutics Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Prostate Cancer Therapeutics Drugs Product Type
Table 24. Date of International Manufacturers Enter into Prostate Cancer Therapeutics Drugs Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Prostate Cancer Therapeutics Drugs Sales by Type (2015-2020) (K Pcs)
Table 27. Global Prostate Cancer Therapeutics Drugs Sales Share by Type (2015-2020)
Table 28. Global Prostate Cancer Therapeutics Drugs Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Prostate Cancer Therapeutics Drugs Revenue Share by Type (2015-2020)
Table 30. Prostate Cancer Therapeutics Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Prostate Cancer Therapeutics Drugs Sales Share by Type (2021-2026)
Table 32. Global Prostate Cancer Therapeutics Drugs Sales by Application (2015-2020) (K Pcs)
Table 33. Global Prostate Cancer Therapeutics Drugs Sales Share by Application (2015-2020)
Table 34. Global Prostate Cancer Therapeutics Drugs Sales Share by Application (2021-2026)
Table 35. Global Prostate Cancer Therapeutics Drugs Sales Market Share Forecast by Application (2021-2026)
Table 36. Global Prostate Cancer Therapeutics Drugs Revenue by Application (2015-2020) (US$ Million)
Table 37. Global Prostate Cancer Therapeutics Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 38. United States Prostate Cancer Therapeutics Drugs Sales (K Pcs) of Key Companies (2015-2020)
Table 39. United States Prostate Cancer Therapeutics Drugs Sales Share by Company (2015-2020)
Table 40. United States Prostate Cancer Therapeutics Drugs Revenue (US$ Million) by Company (2015-2020)
Table 41. United States Prostate Cancer Therapeutics Drugs Sales (K Pcs) by Type (2015-2020)
Table 42. United States Prostate Cancer Therapeutics Drugs Sales Share by Type (2015-2020)
Table 43. United States Prostate Cancer Therapeutics Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 44. United States Prostate Cancer Therapeutics Drugs Price (K Pcs) by Type (2015-2020)
Table 45. United States Prostate Cancer Therapeutics Drugs Sales (K Pcs) by Type (2021-2026)
Table 46. United States Prostate Cancer Therapeutics Drugs Sales Share by Type (2021-2026)
Table 47. United States Prostate Cancer Therapeutics Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 48. United States Prostate Cancer Therapeutics Drugs Revenue Share by Type (2021-2026)
Table 49. United States Prostate Cancer Therapeutics Drugs Price (K Pcs) by Type (2021-2026)
Table 50. United States Prostate Cancer Therapeutics Drugs Sales (K Pcs) by Application (2015-2020)
Table 51. United States Prostate Cancer Therapeutics Drugs Sales Share by Application (2015-2020)
Table 52. United States Prostate Cancer Therapeutics Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 53. United States Prostate Cancer Therapeutics Drugs Sales (K Pcs) by Application (2021-2026)
Table 54. United States Prostate Cancer Therapeutics Drugs Sales Share by Application (2021-2026)
Table 55. United States Prostate Cancer Therapeutics Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 56. United States Prostate Cancer Therapeutics Drugs Revenue Share by Application (2021-2026)
Table 57. North America Prostate Cancer Therapeutics Drugs Sales by Country (2015-2020) (K Pcs)
Table 58. North America Prostate Cancer Therapeutics Drugs Sales Market Share by Country (2015-2020)
Table 59. North America Prostate Cancer Therapeutics Drugs Revenue by Country (2015-2020) (US$ Million)
Table 60. North America Prostate Cancer Therapeutics Drugs Revenue Market Share by Country (2015-2020)
Table 61. Europe Prostate Cancer Therapeutics Drugs Sales by Country (2015-2020) (K Pcs)
Table 62. Europe Prostate Cancer Therapeutics Drugs Sales Market Share by Country (2015-2020)
Table 63. Europe Prostate Cancer Therapeutics Drugs Revenue by Country (2015-2020) (US$ Million)
Table 64. Europe Prostate Cancer Therapeutics Drugs Revenue Market Share by Country (2015-2020)
Table 65. Asia Pacific Prostate Cancer Therapeutics Drugs Sales by Region (2015-2020) (K Pcs)
Table 66. Asia Pacific Prostate Cancer Therapeutics Drugs Sales Market Share by Region (2015-2020)
Table 67. Asia Pacific Prostate Cancer Therapeutics Drugs Revenue by Region (2015-2020) (US$ Million)
Table 68. Asia Pacific Prostate Cancer Therapeutics Drugs Revenue Market Share by Region (2015-2020)
Table 69. Latin America Prostate Cancer Therapeutics Drugs Sales by Country (2015-2020) (K Pcs)
Table 70. Latin America Prostate Cancer Therapeutics Drugs Sales Market Share by Country (2015-2020)
Table 71. Latin Americaa Prostate Cancer Therapeutics Drugs Revenue by Country (2015-2020) (US$ Million)
Table 72. Latin America Prostate Cancer Therapeutics Drugs Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Prostate Cancer Therapeutics Drugs Sales by Country (2015-2020) (K Pcs)
Table 74. Middle East and Africa Prostate Cancer Therapeutics Drugs Sales Market Share by Country (2015-2020)
Table 75. Middle East and Africa Prostate Cancer Therapeutics Drugs Revenue by Country (2015-2020) (US$ Million)
Table 76. Middle East and Africa Prostate Cancer Therapeutics Drugs Revenue Market Share by Country (2015-2020)
Table 77. Johnson & Johnson Corporation Information
Table 78. Johnson & Johnson Description and Business Overview
Table 79. Johnson & Johnson Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Johnson & Johnson Prostate Cancer Therapeutics Drugs Product
Table 81. Johnson & Johnson Recent Development
Table 82. Pfizer, Inc Corporation Information
Table 83. Pfizer, Inc Description and Business Overview
Table 84. Pfizer, Inc Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Pfizer, Inc Product
Table 86. Pfizer, Inc Recent Development
Table 87. AstraZeneca Corporation Information
Table 88. AstraZeneca Description and Business Overview
Table 89. AstraZeneca Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. AstraZeneca Product
Table 91. AstraZeneca Recent Development
Table 92. Amgen, Inc Corporation Information
Table 93. Amgen, Inc Description and Business Overview
Table 94. Amgen, Inc Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Amgen, Inc Product
Table 96. Amgen, Inc Recent Development
Table 97. AbbVie, Inc Corporation Information
Table 98. AbbVie, Inc Description and Business Overview
Table 99. AbbVie, Inc Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. AbbVie, Inc Product
Table 101. AbbVie, Inc Recent Development
Table 102. Bayer AG Corporation Information
Table 103. Bayer AG Description and Business Overview
Table 104. Bayer AG Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Bayer AG Product
Table 106. Bayer AG Recent Development
Table 107. Ipsen Group Corporation Information
Table 108. Ipsen Group Description and Business Overview
Table 109. Ipsen Group Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Ipsen Group Product
Table 111. Ipsen Group Recent Development
Table 112. Sanofi Corporation Information
Table 113. Sanofi Description and Business Overview
Table 114. Sanofi Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. Sanofi Product
Table 116. Sanofi Recent Development
Table 117. Endo Pharmaceuticals Corporation Information
Table 118. Endo Pharmaceuticals Description and Business Overview
Table 119. Endo Pharmaceuticals Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 120. Endo Pharmaceuticals Product
Table 121. Endo Pharmaceuticals Recent Development
Table 122. Dendreon Corporation Corporation Information
Table 123. Dendreon Corporation Description and Business Overview
Table 124. Dendreon Corporation Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 125. Dendreon Corporation Product
Table 126. Dendreon Corporation Recent Development
Table 127. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 128. Key Challenges
Table 129. Market Risks
Table 130. Main Points Interviewed from Key Prostate Cancer Therapeutics Drugs Players
Table 131. Prostate Cancer Therapeutics Drugs Customers List
Table 132. Prostate Cancer Therapeutics Drugs Distributors List
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Prostate Cancer Therapeutics Drugs Product Picture
Figure 2. Global Prostate Cancer Therapeutics Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Hormone Therapy Product Picture
Figure 4. Chemotherapy Product Picture
Figure 5. Biologic Therapy Product Picture
Figure 6. Targeted Therapy Product Picture
Figure 7. Other Product Picture
Figure 8. Global Prostate Cancer Therapeutics Drugs Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital Pharmacy
Figure 10. Retail Pharmacy
Figure 11. Online Sales
Figure 12. Other
Figure 13. Prostate Cancer Therapeutics Drugs Report Years Considered
Figure 14. Global Prostate Cancer Therapeutics Drugs Market Size 2015-2026 (US$ Million)
Figure 15. Global Prostate Cancer Therapeutics Drugs Sales 2015-2026 (K Pcs)
Figure 16. Global Prostate Cancer Therapeutics Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Prostate Cancer Therapeutics Drugs Sales Market Share by Region (2015-2020)
Figure 18. Global Prostate Cancer Therapeutics Drugs Sales Market Share by Region in 2019
Figure 19. Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Region (2015-2020)
Figure 20. Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Region in 2019
Figure 21. Global Prostate Cancer Therapeutics Drugs Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Prostate Cancer Therapeutics Drugs Revenue in 2019
Figure 23. Prostate Cancer Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Prostate Cancer Therapeutics Drugs Sales Market Share by Type (2015-2020)
Figure 25. Global Prostate Cancer Therapeutics Drugs Sales Market Share by Type in 2019
Figure 26. Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Type (2015-2020)
Figure 27. Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Type in 2019
Figure 28. Global Prostate Cancer Therapeutics Drugs Market Share by Price Range (2015-2020)
Figure 29. Global Prostate Cancer Therapeutics Drugs Sales Market Share by Application (2015-2020)
Figure 30. Global Prostate Cancer Therapeutics Drugs Sales Market Share by Application in 2019
Figure 31. Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Application (2015-2020)
Figure 32. Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Application in 2019
Figure 33. United States Prostate Cancer Therapeutics Drugs Sales Growth Rate 2015-2026 (K Pcs)
Figure 34. United States Prostate Cancer Therapeutics Drugs Revenue Growth Rate 2015-2026 (US$ Million)
Figure 35. United States Prostate Cancer Therapeutics Drugs Market Share in Global Market 2015-2026
Figure 36. United States 5 and 10 Largest Prostate Cancer Therapeutics Drugs Players Market Share by Revenue in Prostate Cancer Therapeutics Drugs in 2019
Figure 37. United States Prostate Cancer Therapeutics Drugs Revenue Share by Type (2015-2020)
Figure 38. United States Prostate Cancer Therapeutics Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 39. United States Prostate Cancer Therapeutics Drugs Revenue Share by Application (2015-2020)
Figure 40. United States Prostate Cancer Therapeutics Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 41. North America Prostate Cancer Therapeutics Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 42. North America Prostate Cancer Therapeutics Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. North America Prostate Cancer Therapeutics Drugs Sales Market Share by Country in 2019
Figure 44. North America Prostate Cancer Therapeutics Drugs Revenue Market Share by Country in 2019
Figure 45. U.S. Prostate Cancer Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. U.S. Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Canada Prostate Cancer Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Canada Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Europe Prostate Cancer Therapeutics Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 50. Europe Prostate Cancer Therapeutics Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 51. Europe Prostate Cancer Therapeutics Drugs Sales Market Share by Country in 2019
Figure 52. Europe Prostate Cancer Therapeutics Drugs Revenue Market Share by Country in 2019
Figure 53. Germany Prostate Cancer Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Germany Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. France Prostate Cancer Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. France Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. U.K. Prostate Cancer Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 58. U.K. Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Italy Prostate Cancer Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 60. Italy Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Russia Prostate Cancer Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. Russia Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Asia Pacific Prostate Cancer Therapeutics Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 64. Asia Pacific Prostate Cancer Therapeutics Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 65. Asia Pacific Prostate Cancer Therapeutics Drugs Sales Market Share by Region in 2019
Figure 66. Asia Pacific Prostate Cancer Therapeutics Drugs Revenue Market Share by Region in 2019
Figure 67. China Prostate Cancer Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. China Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Japan Prostate Cancer Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Japan Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. South Korea Prostate Cancer Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. South Korea Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. India Prostate Cancer Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. India Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Australia Prostate Cancer Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Australia Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Taiwan Prostate Cancer Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Taiwan Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Indonesia Prostate Cancer Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Indonesia Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Thailand Prostate Cancer Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Thailand Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Malaysia Prostate Cancer Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Malaysia Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Philippines Prostate Cancer Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 86. Philippines Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Vietnam Prostate Cancer Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 88. Vietnam Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Latin America Prostate Cancer Therapeutics Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 90. Latin America Prostate Cancer Therapeutics Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America Prostate Cancer Therapeutics Drugs Sales Market Share by Country in 2019
Figure 92. Latin America Prostate Cancer Therapeutics Drugs Revenue Market Share by Country in 2019
Figure 93. Mexico Prostate Cancer Therapeutics Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Mexico Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil Prostate Cancer Therapeutics Drugs Sales Gro

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs